Rgenta Therapeutics Announces Strategic Alliance with GSK
2024-12-04

Rgenta Therapeutics Announces Strategic Alliance with GSK

Rgenta Therapeutics announced that it has entered into a multi-year, multi-target strategic research alliance with pharma giant GSK
GenScript to Receive Significant Revenue through its Involvement in $3.3 Billion Deal with Merck
2024-11-15

GenScript to Receive Significant Revenue through its Involvement in $3.3 Billion Deal with Merck

GenScript Biotech announced that its CDMO subsidiary, ProBio, has licensed its PD-1 new molecular entity (NME) to LaNova Medicines
Pulmatrix and Cullgen Announce Proposed Merger
2024-11-13

Pulmatrix and Cullgen Announce Proposed Merger

Pulmatrix and Cullgen have announced a merger to form a Nasdaq-listed entity, focusing on targeted protein degradation
BioNTech to Acquire China’s Biotheus for USD800 Million
2024-11-13

BioNTech to Acquire China’s Biotheus for USD800 Million

BioNTech has reached an agreement to acquire Chinese biopharmaceutical company Biotheus for $800 million
HLC Brings Healthcare Portfolio Companies to Southeast Asia
2024-11-12

HLC Brings Healthcare Portfolio Companies to Southeast Asia

HLC team, along with our portfolio companies and ecosystem partners, embarked on a 5-day business development trip to Thailand and Indonesia.
HighLight Capital invests in ITM
2024-10-08

HighLight Capital invests in ITM

HLC invests in ITM to support ITM's radiopharmaceutical pipeline and to strengthen its leading position in medical radioisotope manufacturing. 
  • 1
  • 2
  • 3
  • 4
  • 5
  • 27 records in total